Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.

Babiy, A V

Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. [electronic resource] - Biochemical pharmacology Mar 1992 - 995-1000 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0006-2952

10.1016/0006-2952(92)90604-h doi


Adult
Arteriosclerosis--etiology
Diabetes Complications
Diabetes Mellitus--blood
Female
Glycosylation
Humans
Lipid Peroxidation--drug effects
Lipoproteins--blood
Lipoproteins, HDL--blood
Lipoproteins, LDL--blood
Male
Middle Aged
Probucol--therapeutic use
Vitamin E--analysis